Advancing translational life sciences research and academic technology transfer

Scientists at The Wistar Institute developed a synthetic DNA approach that instructs in vivo production of a human monoclonal antibody able to neutralize hepatitis B virus (HBV) and prevent infection of liver cells in vitro.

<<FULL STORY>>